Growth Metrics

Integra Lifesciences Holdings (IART) Amortization - Goodwill (2013 - 2025)

Integra Lifesciences Holdings recorded quarterly Amortization - Goodwill of $511.4 million in Q2 2025, up 994.18% quarter-over-quarter from $46.7 million in Q3 2013.

Integra Lifesciences Holdings' Amortization - Goodwill history runs 2 years deep, the most recent figure standing at $511.4 million for Q2 2025.

  • In Q2 2025, Amortization - Goodwill changed N/A year-over-year to $511.4 million; the TTM figure through Dec 2025 stood at $511.4 million (changed N/A YoY), while the FY2025 annual figure was $511.4 million, changed N/A from the prior year.
  • Amortization - Goodwill came in at $511.4 million for Q2 2025 at Integra Lifesciences Holdings, up from $46.7 million in the prior quarter.
  • In the past five years, Amortization - Goodwill ranged from a high of $511.4 million in Q2 2025 to a low of $511.4 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Integra Lifesciences Holdings 1.20 Bn 939.16 Mn 216.98 Mn

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 511.40 Mn
Sep 30, 2013 46.74 Mn